An in vivo breast cancer model established by the subcutaneous inoculation of MDA-MB-123 cells as a xenograft in nude mice also demonstrated tumor regression in IGHG1-silenced cells consistent with previous studies in prostate [18], colorectal, and gastric cancers [9, 19]. Here, IGHG1 is linked to breast cancer.